Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04616274. IPD Sharing: NO. Countries: 1. Publications: 0.
Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01849939. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
ClinicalTrials.gov study NCT03513562. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00083473. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Ambulatory Medical Assistance Nurse Program in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT05350826. IPD Sharing: NO. Countries: 1. Publications: 0.
17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
ClinicalTrials.gov study NCT00098488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00002838. IPD Sharing: Not stated. Countries: 1. Publications: 0.
STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00015860. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03701282. IPD Sharing: YES. Countries: 2. Publications: 0.
Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06377501. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01886859. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00337519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00947388. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy
ClinicalTrials.gov study NCT00004040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)
ClinicalTrials.gov study NCT01295593. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01410513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT06364423. IPD Sharing: YES. Countries: 1. Publications: 0.
Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT05943496. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01534715. IPD Sharing: NO. Countries: 2. Publications: 0.
A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01463852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.